Are there sex differences among colorectal cancer patients in treatment and survival? A Swiss cohort study
Open Access
- 4 March 2021
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 147 (5) , 1407-1419
Abstract
Background: Colorectal cancer (CRC) is among the three most common incident cancers and causes of cancer death in Switzerland for both men and women. To promote aspects of gender medicine, we examined differences in treatment decision and survival by sex in CRC patients diagnosed 2000 and 2001 in the canton of Zurich, Switzerland. Methods: Characteristics assessed of 1076 CRC patients were sex, tumor subsite, age at diagnosis, tumor stage, primary treatment option and comorbidity rated by the Charlson Comorbidity Index (CCI). Missing data for stage and comorbidities were completed using multivariate imputation by chained equations. We estimated the probability of receiving surgery versus another primary treatment using multivariable binomial logistic regression models. Univariable and multivariable Cox proportional hazards regression models were used for survival analysis. Results: Females were older at diagnosis and had less comorbidities than men. There was no difference with respect to treatment decisions between men and women. The probability of receiving a primary treatment other than surgery was nearly twice as high in patients with the highest comorbidity index, CCI 2+, compared with patients without comorbidities. This effect was significantly stronger in women than in men (p-interaction = 0.010). Survival decreased with higher CCI, tumor stage and age in all CRC patients. Sex had no impact on survival. Conclusion: The probability of receiving any primary treatment and survival were independent of sex. However, female CRC patients with the highest CCI appeared more likely to receive other therapy than surgery compared to their male counterparts.Keywords
Funding Information
- Alfred und Anneliese Sutter-Stöttner Stiftung
- Krebsliga Zürich
- Universität Zürich
This publication has 55 references indexed in Scilit:
- The impact of comorbidity on cancer survival: a reviewClinical Epidemiology, 2013
- Overall survival after resection for colon cancer in a national cohort study was adversely affected by TNM stage, lymph node ratio, gender, and old ageInternational Journal of Colorectal Disease, 2011
- The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort studyBMC Cancer, 2009
- Predicting in-hospital mortality in patients with cirrhosis: Results differ across risk adjustment methods #Hepatology, 2009
- What Improves with Increased Missing Data Imputations?Structural Equation Modeling: A Multidisciplinary Journal, 2008
- Gender differences in colorectal cancer: implications for age at initiation of screeningBritish Journal of Cancer, 2007
- Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancerBritish Journal of Surgery, 2005
- Male gender adversely affects survival following surgery for colorectal cancerBritish Journal of Surgery, 2003
- Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: Reduction in local treatment failureEuropean Journal of Cancer, 1994
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987